Detalles de la búsqueda
1.
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial.
Lancet;
402(10397): 185-195, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37290461
2.
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Lancet Oncol;
24(11): 1252-1265, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37844597
3.
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
Genet Med;
23(4): 698-704, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33442023
4.
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
BJU Int;
128(2): 254-261, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547860
5.
Insights into the Use of Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
Curr Treat Options Oncol;
22(3): 26, 2021 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635493
6.
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.
Mod Pathol;
33(12): 2580-2590, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32616874
7.
Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.
Oncology (Williston Park);
34(8): 317-319, 2020 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32785928
8.
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma.
Br J Cancer;
118(9): 1238-1242, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29674707
9.
Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
Oncologist;
22(3): 286-292, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28220024
10.
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer;
122(3): 411-9, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26540173
11.
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies.
Cancer;
122(15): 2389-98, 2016 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27198170
12.
Optimising first-line treatment for metastatic renal cell carcinoma.
Lancet;
395(10219): e7, 2020 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31954470
13.
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
J Natl Compr Canc Netw;
14(7): 820-4, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27407122
14.
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
BMC Cancer;
14: 779, 2014 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25342282
15.
Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review.
Cancer Treat Rev;
122: 102652, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980876
16.
Case-control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study.
Clin Transl Oncol;
26(3): 732-738, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556096
17.
Successful Pregnancy and Cancer Outcomes With Ipilimumab and Nivolumab for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature.
J Immunother;
46(1): 27-28, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327112
18.
Meta-analysis of perioperative immunotherapy in renal cell carcinoma: Available, but the jury is still out.
Urol Oncol;
41(9): 391.e13-391.e21, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331822
19.
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors.
J Immunother Cancer;
11(1)2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627145
20.
PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer.
Am J Cancer Res;
13(5): 2116-2125, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37293154